Petroreconcavo (RECV3) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
18 Jun, 2026Reserve certification and growth
2P reserves for 2025 certified at 182.2 MMBOE, supporting 19 years of production at current pace.
Reserve Replacement Ratio (RRR) maintained at 1.0x, indicating full replacement of produced reserves.
Future reserves development cost estimated at US $8.4/boe, with PV10 value of US $2.4 billion.
43% of total 2P reserves are gas, highlighting a balanced portfolio.
Recovery factors for oil and gas show potential for further expansion, benchmarking favorably against industry standards.
Production and cash flow outlook
WI production projected to remain stable, ranging from 26 to 37 kboe/day through 2035.
Operating cash flow expected to be robust, with a growth trajectory supported by consistent production.
Lower Brent price curve and increased lifting costs partially offset by reduced midstream costs.
Operating cash flow after CAPEX remains strong, with PV10 at US $2.4 billion for 2025.
Certification highlights operational resilience and adaptability to market changes.
Capital expenditure and cost management
2P development CAPEX for the next five years averages around US $130 million annually.
2P reserve development cost remains stable at approximately US $8.4/boe.
Short-term CAPEX reduction achieved through exchange rate gains and project optimization.
Expansion of secondary recovery projects supports long-term reserve growth.
CAPEX allocation is closely aligned with operating cash flow to ensure financial discipline.
Latest events from Petroreconcavo
- Strong financials, operational efficiency, and ESG focus drive sustainable growth and returns.RECV3
Investor presentation13 Jul 2026 - Record revenue and EBITDA in 2024, with strong cash flow and high dividend yield.RECV3
Q4 202410 Jul 2026 - Net revenue hit R$1.57 billion in H1 2024, with record EBITDA and strong cash flow growth.RECV3
Q2 202410 Jul 2026 - Record revenue, strong cash flow, and robust dividends support growth and resilience.RECV3
Q3 202410 Jul 2026 - Q3 saw lower revenue and profit, but YTD net income rose on asset gains and risk management.RECV3
Q3 202510 Jul 2026 - Net income more than doubled sequentially as cost controls and cash flow enabled equity distribution.RECV3
Q1 202610 Jul 2026 - Net income up 107% and EBITDA up 20% on higher revenue, cash flow, and cost control.RECV3
Q1 202510 Jul 2026 - Net income rose 46% to R$ 638 million on resilient operations, cost control, and midstream gains.RECV3
Q4 202510 Jul 2026 - Net income rose 5% sequentially as revenue and EBITDA fell, with strategic investments advancing.RECV3
Q2 202510 Jul 2026